Loading...
Dose selection and population pharmacokinetics of PEG-Intron in patients with chronic myelogenous leukaemia
AIMS: To assess the dose selection using population pharmacokinetics of Pegylated Intron-α2b (PEG-Intron) in patients with chronic myelogenous leukaemia (CML). METHODS: PEG-Intron 3–6 µg kg(−1) was administered subcutaneously once a week and blood samples were collected up to 48 weeks of treatment....
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Blackwell Science Inc
2007
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2000735/ https://ncbi.nlm.nih.gov/pubmed/16939523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2006.02757.x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|